The role of gender in the progression of renal disease

Advances in Renal Replacement Therapy

Volumn 10, Issue 1, 2003, Pages 3-14

  Silbiger, Sharon R ^a,b   Neugarten, Joel ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Androgens; Estrogen; Gender; Progression of renal disease; Renal disease

Indexed keywords

CYTOKINE; ESTROGEN; SEX HORMONE; TESTOSTERONE;

BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; DIET; DISEASE COURSE; GENDER; GLOMERULAR STRUCTURE; HEMODYNAMICS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY DISEASE; KIDNEY POLYCYSTIC DISEASE; MEMBRANOUS GLOMERULONEPHRITIS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0037288810     PISSN: 10734449     EISSN: None     Source Type: Journal    
DOI: 10.1053/jarr.2003.50001     Document Type: Review

References (139)

1. Neugarten J, Acharya A, Silbiger SR: Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol 11:319-329, 2000
2. Anderson S: Mechanisms of injury in progressive renal disease. Exp Nephrol 4:34-40, 1996 (suppl)
3. Klahr S, Morrissey JJ: The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease. Kidney Int Suppl 75:S7-14, 2000
4. Kasiske BL, Umen JA: The influence of age, sex, race and body habitus on kidney weight in humans. Arch Pathol Lab Med 110:55-60, 1986
5. Oudar O, Elger M, Bankir L, et al: Differences in renal kidney morphology between males, females and testosterone-treated females. Renal Physiol Biochem 14:92-102, 1991
6. Jean-Faucher C, Berger M, Gallon C, et al: Sex-related differences in renal size in mice: Ontogeny and influence of neonatal androgens. J Endocrinol 115:241-246, 1987
7. Moell H: Size of normal kidneys. Acta Radiol 46:640645, 1956
8. Lattimer JK: The action of testosterone propionate upon the kidneys of rats, dogs and men. J Urol 48:778-794, 1942
9. Remuzzi A, Puntorieri S, Mazzoleni A, et al: Sex related differences in glomerular ultrafiltration and proteinuria in Munich-Wistar rats. Kidney Int 34:481-486, 1988
10. Munger K, Baylis C: Sex differences in renal hemodynamics in rats. Am J Physiol 254:F223-231, 1988
11. Solomon S: Developmental changes in nephron number, proximal tubular length and superficial nephron glomerular filtration rate of rats. J Physiol (Lond) 272:573-589, 1977
12. McLachlan MS, Guthrie JC, Anderson CK, et al: Vascular and glomerular changes in the ageing kidney. J Pathol 121:65-77, 1976
13. McLachlan MS, Gaunt A, Fulker MJ, et al: Estimation of glomerular size and number from radiographs of the kidney. Br J Radiol 49:831-835, 1976
14. Neugarten J, Kasiske B, Silbiger SR, et al: Effects of sex on renal structure. Nephron 90:139-144, 2002
15. Reckelhoff JF: Gender differences in the regulation of blood pressure. Hypertension 37:1199-1208, 2001
16. Okuniewski R, Davis EA, Jarrott B, et al: A comparison of the development of renal hypertension in male and female rats. Clin Sci (Lond) 95:445-451, 1998
17. Silbiger S, Lei J, Ziyadeh FN, et al: Estradiol reverses TGFβ1-stimulated type IV collagen gene transcription in murine mesangial cells. Am J Physiol 274: F1113-F1118, 1998
18. Neugarten J, Ding Q, Friedman A, et al: Sex hormones and renal nitric oxide synthases. J Am Soc Nephrol 8:1240-1246, 1997
19. Xiao S, Gillespie DG, Baylis C, et al: Effects of estradiol and its metabolites on glomerular endothelial nitric oxide synthesis and mesangial cell growth. Hypertension 37:645-650, 2001
20. Lee HS: Oxidized LDL, glomerular mesangial cells and collagen. Diabetes Res Clin Pract 45:117-122, 1999
21. Silbiger S, Ghossein C, Neugarten J: Estradiol inhibits mesangial cell mediated oxidation of low density lipoprotein. J Lab Clin Med 126:385-391, 1995
22. Kwan G, Neugarten J, Sherman M, et al: Effects of sex hormones on mesangial cell proliferation and collagen synthesis. Kidney Int 50:1173-1179, 1996
23. Dubey RK, Gillespie DG, Keller PJ, et al: Role of methoxyestradiols in the growth inhibitory effects of estradiol on human glomerular mesangial cells. Hypertension 39:418-424, 2002
24. Guccione M, Silbiger S, Lei J, et al: Estradiol upregulates mesangial cell MMP-2 activity via transcription factor AP-2. Am J Physiol 282: F164-169, 2001
25. Haley DP, Bulger RE: The aging male rat: Structure and function of the kidney. Am J Anat 167:1-13,1983
26. Gilboa N, Magro AM, Han Y, et al: Contrasting effects of early and late orchiectomy on hypertension and renal disease in Fawn-hooded rats. Life Sci 41:1629-1634, 1987
27. Baylis C, Corman B: The aging kidney: insights from experimental studies. J Am Soc Nephrol 9:699-709, 1988
28. Lombet JR, Adler SG, Anderson PS, et al: Sex vulnerability in the subtotal nephrectomy model of glomerulosclerosis in the rat. J Lab Clin Med 114:66-74, 1989
29. Zeier M, Gretz N: The influence of gender on the progression of renal failure, in Zeier M, Gretz N (eds): Experimental and Genetic Rat Models of Chronic Renal Failure. Basel, Karger, 1993, pp 250-257
30. Baylis C, Wilson CB: Sex and the single kidney. Am J Kidney Dis 13:290-298, 1989
31. Cowley BD Jr, Rupp JC, Muessel MJ, et al: Gender and the effect of gonadal hormones on the progression of inherited polycystic kidney disease in rats. Am J Kidney Dis 29:265-272, 1997
32. Sakemi T, Tomiyoshi Y, Miyazono M, et al: Estrogen replacement therapy with its physiological dose does not eliminate the aggravating effect of ovariectomy on glomerular injury in hypercholesterolemic female Imai rats. Nephron 80:324-330, 1998
33. Carraro-Eduardo JC, Oliveira AV, Carrapatoso ME, et al: Effect of sex hormones on gentamicin-induced neprhotoxicity in rats. Braz J Med Biol Res 26:653-662, 1993
34. Sakemi T, Baba N: Castration attenuates proteinuria and glomerular injury in hyperlipidemic male Imai rats. Nephron 64:429-435, 1993
35. Joles JA, van Goor H, Koomans HA: Estrogen induces glomerulosclerosis in analbuminemic rats. Kidney Int 53:862-868, 1998
36. Cohen AM, Rosenmann E: Effect of the estrogen antagonist, tamoxifen, on the development of glomerulosclerosis in the Cohen diabetic rat. Diabetes 34:634-638, 1985
37. Rosenmann E, Yanko L, Cohen AM: Female sex hormone and nephropathy in Cohen diabetic rat (genetically selected sucrose-fed). Horm Metab Res 16:11-16, 1984
38. Baylis C: Age-dependent glomerular damage in the rat. Dissociation between glomerular injury and both glomerular hypertension and hypertrophy. Male gender as a primary risk factor. J Clin Invest 94:1823-1829, 1994
39. Sakemi T, Ohtsuka N, Shouno Y, Morito F: Effect of ovariectomy on glomerular injury in hypercholesterolemic female Imai rats. Nephron 72:72-78, 1996
40. Iam SG, Wexler BC: Inhibition of the development of spontaneous hypertension in SH rats by gonadectomy or estradiol. J Lab Clin Med 94:608-616, 1979
41. Velasquez MT, Bhathena SJ: Dietary phytoestrogens: A possible role in renal disease protection. Am J Kidney Dis 37:1056-1068, 2001
42. Ishikawa I, Maeda K, Nakai S, et al: Gender difference in the mean age at the induction of hemodialysis in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 35:1072-1075, 2000
43. Fick-Brosnahan GM, Belz MM, McFann KK, et al: Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: A longitudinal study. Am J Kidney Dis 39:1127-1134, 2002
44. Crook ED: Diabetic renal disease in African Americans. Am J Med Sci 323:78-84, 2002
45. Brancati FL, Kao WH, Folsom AR, et al: Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. JAMA 283:2253-2259, 2000
46. Torffvit O, Agardh CD: The impact of metabolic and blood pressure control on incidence and progression of nephropathy. A 10-year study of 385 type 2 diabetic patients. J Diabetes Complications 15:307-313, 2001
47. Breyer JA, Bain RP, Evans JK, et al, and the Collaborative Study Group: Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. Kidney Int 50:1651-1658, 1996
48. Hovind P, Tarnow L, Oestergaard PB, et al: Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy. Kidney Int Suppl 75:S56-61, 2000
49. Jacobsen P, Rossing K, Tarnow K, et al: Progression of diabetic nephropathy in normotensive type 1 diabetic patients. Kidney Int Suppl 71:S101-105, 1999
50. USRDS: 1997 Annual Data Report, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health. Table A.7, Table A.11
51. MacKay LL, MacKay EM: Factors which determine renal weight. III. Sex. Am J Physiol 83:196-201, 1927
52. Hall VE, MacGregor WW: Relation of kidney weight to body weight in the cat. Anat Rec 69:319-325, 1937
53. Kochakian CD: Regulation of kidney growth by androgens. Adv Steroid Biochem Pharmacol 6:1-34, 1977
54. Mulroney SE, Woda C, Johnson M, et al: Gender differences in renal growth and function after uninephrectomy in adult rats. Kidney Int 56:944-953, 1999
55. Mulroney SE, Pesce C: Early hyperplastic renal growth after uninephrectomy in adult female rats. Endocrinology 141:932-937, 2000
56. Murray BM, Brown GP, Schoenl M: Interaction of gender and dietary protein on renal growth and the renal growth hormone-insulin-like growth factor axis. J Lab Clin Med 131:360-369, 1998
57. Arataki M: On the postnatal growth of the kidney, with special reference to the number and size of the glomeruli (albino rat). Am J Anat 36:399-435, 1926
58. Broulik PD: The effect of castration and androgen treatment on glomerular volume in mice. Exp Clin Endocrinol 82:115-117, 1983
59. Gafter U, Ben-Bassat M, Levi J: Castration inhibits glomerular hypertrophy and proteinuria in uninephrectomized male rats. Eur J Clin Invest 20:360-365, 1990
60. Marcatoni C, Jafar TH, Oldrizzi L et al: The role of systemic hypertension in the progression of nondiabetic renal disease. Kidney Int Suppl 75:S44-48, 2000
61. Chantrel F, Moulin B, Hannedouche T: Blood pressure, diabetes and diabetic nephropathy. Diabetes Metab 26:37-44, 2000
62. Cirillo M, Stellato D, Laurenzi M, et al: Pulse pressure and isolated systolic hypertension: association with microalbuminuria. The GUBBIO study Collaborative Research Group. Kidney Int 58:1211-1218, 2000
63. Ouchi Y, Share L, Crofton JT, et al: Sex difference in the development of deoxycorticosterone salt hypertension in the rat. Hypertension 9:172-177, 1987
64. Schlager G: Genetic and physiological studies of blood pressure in mice. Can J Genet Cytol 10:833-864, 1968
65. Ganten U, Schroder G, Witt M, et al: Sexual dimorphism of blood pressure in spontaneously hypertensive rats: Effects of anti-androgen treatment. J Hypertens 7:721-726, 1989
66. Chen YF, Meng QC: Sexual dimorphism of blood pressure in spontaneously hypertensive rats is androgen dependent. Life Sci 48:85-96, 1991
67. Anastos K, Charney P, Charon RA, et al: Hypertension in women: What is really known? Ann Intern Med 115:287-293, 1991
68. Buckalew VM Jr, Berg RL, Wang SR, et al: Prevalence of hypertension in 1,795 subjects with chronic renal disease: The modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group. Am J Kidney Dis 28:811-821, 1996
69. Wiinberg N, Hoegholm A, Christensen HR, et al: 24-h ambulatory blood pressure in 352 normal Danish subjects, related to age and gender. Am J Hypertens 8:978-986, 1995
70. Dubey RK, Oparil S, Imthurn B, et al: Sex hormones and hypertension. Cardiovasc Res 53:688-708, 2002
71. Lopes AAS, Port FK, James SA, et al: The excess risk of treated end-stage renal disease in blacks in the United States. J Am Soc Nephrol 3:1961-1971, 1993
72. McClellan W, Tuttle E, Issa A: Racial differences in the incidence of hypertensive end-stage renal disease are not entirely explained by differences in the prevalence of hypertension. Am J Kidney Dis 12:285-290, 1988
73. Gabow PA, Johnson AM, Kaehny WD, et al: Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int 41:1311-1319, 1992
74. Blantz RC, Peterson OW, Blantz ER, et al: Sexual differences in glomerular ultrafiltration: Effect of androgen administration in ovariectomized rats. Endocrinology 122:767-773, 1988
75. Parekh N, Zou A-P, Junling I, et al: Sex differences in control of renal outer medullary circulation in rats: role of prostaglandins. Am J Physiol 264:F629-F636, 1993
76. Eloy L, Grunfeld J-P, Bayle F, et al: Papillary plasma flow in rats. II. Hormonal control. Pflugers Arch 398:253-258, 1983
77. Smith HW: The Kidney, Structure and Function in Health and Disease. New York, NY, Oxford University Press, 1951
78. Wesson LG: Renal hemodynamics in physiological states, in The Physiology of the Human Kidney. New York, NY, Grune & Stratton, 1969, pp 96-106
79. PAH in healthy donors before and after nephrectomy. Mayo Clin Proc 51:296-300, 1976
80. Klopp C, Young NF, Taylor HC: The effects of testosterone and of testosterone propionate on renal functions in man. J Clin Invest 24:189-191, 1945
81. Dignam WS, Voskian J, Assali NS: Effects of estrogens on renal hemodynamics and excretion of electrolytes in human subjects. J Clin Endocrinol 16:1032-1041, 1956
82. Kleinknecht C, Laouari D: The influence of dietary components on experimental renal disease, in Mitch WE (ed): The Progressive Nature of Renal Disease. New York, Churchill Livingstone, 1986, pp 17-35
83. Keenan KP, Coleman JB, McCoy CL, et al: Chronic nephropathy in ad libitum overfed Sprague-Dawley rats and its early attenuation by increasing degrees of dietary (caloric) restriction to control growth. Toxicol Pathol 28:788-798, 2000
84. Cowley BD, Grantham JJ, Muessel MJ, et al: Modification of disease progression in rats with inherited polycystic kidney disease. Am J Kidney Dis 27:865-879, 1996
85. Macconi D, Laurens W, Paris S, et al: Selective dietary restriction of protein and calorie intakes prevents spontaneous proteinuria in male MWF rats. Exp Nephrol 5:404-413, 1997
86. Bourgoignie JJ, Gavellas G, Sabnis SG, et al: Effect of protein diets on the renal function of baboons (Papio hamadryas) with remnant kidneys: A 5-year followup. Am J Kidney Dis 23:199-204, 1994
87. Klahr S, Levey AS, Beck GJ, et al, for the Modification of Diet in Renal Disease Study Group: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 330:877-884, 1994
88. Keane WR: The role of lipids in renal disease: future challenges. Kidney Int Suppl 75:S27-31, 2000
89. Buemi M, Senatore M, Corica F, et al: Statins and progressive renal disease. Med Res Rev 22:76-84, 2002
90. Knopp RH: Cardiovascular effects of endogenous and exogenous sex hormones over a woman's lifetime. Am J Obstet Gynecol 158:1630-1643, 1988
91. Bush TL, Barrett-Connor E, Cowan KD, et al: Cardiovascular mortality and non-contraceptive use of estrogen in women: results from the Lipid Research Clinics' Program Follow-Up Study. Circulation 75:1002-1009, 1987
92. Pickar JH, Wild RA, Walsh B, et al: Effects of different hormone replacement regimens on postmenopausal women with abnormal lipid levels. Menopause Study Group. Climacteric 1:26-32, 1998
93. Ma PTS, Yamamoto T, Goldstein JL, et al: Increased mRNA for low density lipoprotein receptor in livers of rabbits treated with 17-ethinyl estradiol. Proc Natl Acad Sci USA 83:792-796, 1986
94. Masuzaki H, Jingami H, Yamamoto T, et al: Effects of estradiol on very low density lipoprotein receptor mRNA levels in rabbit heart. FEBS Lett 347:211-214, 1994
95. Subbiah MTR: Effect of estrogens on the activities of cholesteryl ester synthetase and cholesteryl ester hydrolases in pigeon aorta. Steroids 30:259-265, 1977
96. Blum A, Cannon RO III: Selective estrogen receptor modulator effects on serum lipoproteins and vascular function in postmenopausal women and in hypercholesterolemic men. Ann N Y Acad Sci 949:168-174, 2001
97. Schnackenberg CG: Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature. Am J Physiol Regul Integr Comp Physiol 282:R335-3452, 2002
98. Stratta R, Cananvese C, Dogliani M, et al: The role of free radicals in the progression of renal disease. Am J Kidney Dis 17:33-37, 1991 (suppl 1)
99. Kerjaschki D: Pathogenetic concepts of membranous glomerulopathy (MGN). J Nephrol 13:S96-100, 2000 (suppl 3)
100. Muaki K, Daifuku K, Yokoyama S, et al: Stoppedflow investigation of antioxidant activity of estrogens in solution. Biochim Biophys Acta 1035:348-355, 1990
101. Maziere C, Auclair M, Ronvewaux MF, et al: Estrogens inhibit copper and cell-mediated modification of low density lipoprotein. Atherosclerosis 89:175-182, 1991
102. Schwenke DC: Aging, menopause and free radicals. Semi Reproduc Endocrinol 16:281-308, 1998
103. Gaedeke J, Peters H, Noble NA, Border WA: Angiotensin II, TGF-beta and renal fibrosis. Contrib Nephrol 135:153-160, 2001
104. Chen S, Hong SW, Iglesias-de la Cruz MC, et al: The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy. Ren Fail 23:471-481, 2001
105. Hansch GM, Wagner C, Burger B, et al: Matrix protein synthesis by glomerular mesangial cells in culture: effects of transforming growth factor β (TGFβ) and platelet-derived growth factor (PDGF) on fibronectin and collagen type IV mRNA. J Cell Physiol 163:451-457, 1995
106. Bruijn JA, Roos A, de Geus B, et al: Transforming growth factor-β and the glomerular extracellular matrix in renal pathology. J Lab Clin Med 123:34-47, 1994
107. Patel P, Varghese E, Ding G, et al: Transforming growth factor beta induces mesangial cell apoptosis through NO- and p53-dependent and independent pathways. J Invest Med 48:403-410, 2000
108. Zdunek M, Silbiger S, Lei J, et al: Protein kinase CK2 mediates TGF-β1-stimulated type IV collagen gene transcription and its reversal by estradiol. Kidney Int 60:2097-2108, 2001
109. Matsuda T, Yamamoto T, Muraguchi A, et al: Crosstalk between transforming growth factor-beta and estrogen receptor signaling through Smad3. J Biol Chem 276:42908-42914, 2001
110. Muller V, Szabo A, Viklicky O, et al: Sex hormones and gender-related differences: their influence on chronic renal allograft rejection. Kidney Int 55:2011-2020, 1999
111. Shaul PW: Regulation of endothelial nitric oxide synthase: location, location, location. Annu Rev Physiol 64:749-774, 2002
112. Attia DM, Ni ZN, Boer P, et al: Proteinuria is preceded by decreased nitric oxide synthesis and prevented by a NO donor in cholesterol-fed rats. Kidney Int 61:1776-1787, 2002
113. Cattell V: Nitric oxide and glomerulonephritis. Kidney Int 61:816-821, 2002
114. Ketteler M, Westenfeld R, Gawlik A, et al: Nitric oxide synthase isoform expression in acute versus chronic anti-Thy 1 nephritis. Kidney Int 61:826-833, 2002
115. Zhang L, Kosaka H: Sex-specific acute effect of estrogen on endothelium-derived contracting factor in the renal artery of hypertensive Dahl rats. J Hypertens 20:237-246, 2002
116. Blantz RC, Deng A, Lorti M, et al: The complex role of nitric oxide in the regulation of glomerular ultrafiltration. Kidney Int 61:782-785, 2002
117. Pautz A, Franzen R, Dorsch S, et al: Cross-talk between nitric oxide and superoxide determines ceramide formation and apoptosis in glomerular cells. Kidney int 61:790-796, 2002
118. Mikkola T, Viinikka L, Ylikorkala O: Estrogen and postmeopausal estrogen/progestin therapy: effect on endothelium-dependent prostacyclin, nitric oxide and endothelin-1 production. Eur J Obstet Gynecol Reprod Biol 79:75-82, 1998
119. Stefano GB, Peter D: Cell surface estrogen receptors coupled to cNOS mediate immune and vascular tissue regulation: therapeutic implications. Med Sci Monit 7:1066-1074, 2001
120. Reckelhoff JF, Hennington BS, Moore AG, et al: Gender differences in the renal nitric oxide (NO) system: dissociation between expression of endothelial NO synthase and renal hemodynamic response to NO synthase inhibition. Am J Hypertens 11:97-104, 1998
121. Verhgen AM, Attia DM, Koomans HA, et al: Male gender increases sensitivity to proteinuria induced by mild NOS inhibition in rats: Role of sex hormones. Am J Physiol 279:F664-670, 2000
122. Kang AK, Miller JA: Effects of gender on the reninangiotensin system, blood pressure, and renal function. Curr Hypertens Rep 4:143-151, 2002
123. Miller JA, Anacta LA, Cattran DC: Impact of gender on the renal response to AII. Kidney Int 55:278-285, 1999
124. Oelkers WK: Effects of estrogens and progestogens on the renin angiotensinogen system and blood pressure. Steroids 61:166-171, 1996
125. Nickenig G, Baumer AT, Grohe C, et al: Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation 97:2197-2201, 1998
126. Neugarten J, Acharya A, Lei J, et al: Selective estrogen receptor modulators suppress mesangial cell collagen synthesis. Am J Physiol 279:F309-318, 2000
127. Gallagher PE, Li R, Lenhart JR, et al: Estrogen regulation of angiotensin-converting enzyme mRNA. Hypertension 33:323-328, 1999
128. Chen YF, Naftilan AJ, Oparil S: Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats. Hypertension 19:456-463, 1992
129. Najletti A, Matsunaga M, Masson GMC: Effect of sex hormones on the renal pressor system. Can J Physiol Pharmacol 49:292-301, 1971
130. Ruggenenti P, Perna A, Zoccali C, et al: Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: differences between women and men in relation to the ACE gene polymorphism. Gruppo Italiano di Studi Epidemologici in Nefrologia (Gisen). J Am Soc Nephrol 11:88-96, 2000
131. Beldekas JC, Gerstenfeld L, Sonensheim GE, et al: Cell density and estradiol modulation of procollagen type III in cultured calf smooth muscle cells. J Biol Chem 257:12252-12256, 1982
132. Kasperk CH, Wergedal JE, Farley JR, et al: Androgens directly stimulate proliferation of bone cells in vitro. Endocrinology 124:1576-1578, 1989
133. Sakyo K, Ito A, Mori Y: Dehydroepiandrosterone sulfate stimulates collagenase synthesis without affecting the rates of collagen and noncollagen protein synthesis by rabbit uterine cervical fibroblasts. Biol Reprod 36:277-281, 1987
134. Fisher GM, Swain ML: Effect of sex hormones on blood pressure and vascular connective tissue in castrated and noncastrated male rats. Am J Physiol 232:H617-621, 1977
135. Fischer GM, Swain ML: Effects of estradiol and progesterone on the increased synthesis of collagen in atherosclerotic rabbit aortas. Atherosclerosis 54:177-185, 1985
136. Fischer GM, Bashey RI, Rosenbaum H, et al: A possible mechanism in arterial wall for mediation of sex difference in atherosclerosis. Exp Mol Pathol 43:288-296, 1985
137. Silbiger S, Lei J, Neugarten J: Estradiol suppresses type I collagen synthesis in mesangial cells via activation of activator protein-1. Kidney Int 55:1268-1276, 1999
138. Potier M, Ellio SJ, Tack I, et al: Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9. J Am Soc Nephrol 12:241-251, 2001
139. Potier M, Zheng KM, Elliot SJ, et al: Estrogen-related abnormalities in glomerulosclerosis-prone mice: reduced mesangial cell estrogen receptor expression and prosclerotic response to estrogens. Am J Pathol 160:1877-1885, 2002